NeuroBo Pharmaceuticals Inc (NRBO)
3.32
+0.03
(+0.91%)
USD |
NASDAQ |
Sep 27, 16:00
3.25
-0.07
(-2.11%)
After-Hours: 20:00
NeuroBo Pharmaceuticals Total Return Level: 3.32 for Sept. 27, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
September 27, 2024 | 3.32 |
September 26, 2024 | 3.29 |
September 25, 2024 | 3.32 |
September 24, 2024 | 3.20 |
September 23, 2024 | 3.19 |
September 20, 2024 | 3.19 |
September 19, 2024 | 3.26 |
September 18, 2024 | 3.40 |
September 17, 2024 | 3.43 |
September 16, 2024 | 3.44 |
September 13, 2024 | 3.61 |
September 12, 2024 | 3.65 |
September 11, 2024 | 3.75 |
September 10, 2024 | 3.88 |
September 09, 2024 | 4.11 |
September 06, 2024 | 3.50 |
September 05, 2024 | 3.357 |
September 04, 2024 | 3.37 |
September 03, 2024 | 3.509 |
August 30, 2024 | 3.69 |
August 29, 2024 | 3.51 |
August 28, 2024 | 3.48 |
August 27, 2024 | 3.46 |
August 26, 2024 | 3.41 |
August 23, 2024 | 3.40 |
Date | Value |
---|---|
August 22, 2024 | 3.65 |
August 21, 2024 | 3.77 |
August 20, 2024 | 3.77 |
August 19, 2024 | 3.76 |
August 16, 2024 | 3.66 |
August 15, 2024 | 3.900 |
August 14, 2024 | 3.90 |
August 13, 2024 | 3.78 |
August 12, 2024 | 3.69 |
August 09, 2024 | 3.60 |
August 08, 2024 | 3.80 |
August 07, 2024 | 3.81 |
August 06, 2024 | 3.832 |
August 05, 2024 | 3.57 |
August 02, 2024 | 3.985 |
August 01, 2024 | 3.78 |
July 31, 2024 | 4.07 |
July 30, 2024 | 4.10 |
July 29, 2024 | 4.22 |
July 26, 2024 | 4.15 |
July 25, 2024 | 4.095 |
July 24, 2024 | 4.085 |
July 23, 2024 | 4.30 |
July 22, 2024 | 4.34 |
July 19, 2024 | 4.51 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.02
Minimum
Apr 23 2024
7200.00
Maximum
Feb 12 2020
757.05
Average
200.08
Median
Total Return Level Benchmarks
Geovax Labs Inc | 2.45 |
Atara Biotherapeutics Inc | 8.075 |
Elutia Inc | 3.85 |
NovaBay Pharmaceuticals Inc | 0.71 |
Palatin Technologies Inc | 0.8406 |